Related Experiment Videos
Viruses and cancer. Causal associations
1Yale University School of Medicine, New Haven, CT.
Annals of Epidemiology
|October 1, 1990
Summary
Establishing a virus-cancer link involves challenges. While Hepatitis B virus and Human T-cell leukemia virus show strong links to cancers, others like Epstein-Barr and Human Papilloma viruses have less conclusive associations.
Area of Science:
- Oncology
- Virology
- Epidemiology
Background:
- Viruses are implicated in a significant proportion of human cancers.
- Establishing definitive causal links between specific viruses and cancers is complex.
- Several viruses are considered candidate oncogenic agents in human carcinogenesis.
Purpose of the Study:
- To review general challenges in establishing virus-cancer causality.
- To assess the strength of evidence for causal associations between candidate oncogenic viruses and associated human cancers.
- To identify areas where evidence is strong, moderate, incomplete, or inconclusive.
Main Methods:
- Literature review and synthesis of existing evidence.
- Evaluation of established guidelines for determining viral carcinogenicity.
- Categorization of virus-cancer associations based on current scientific consensus.
Main Results:
- Strong causal links exist for Hepatitis B virus (HBV) and hepatocellular carcinoma, and Human T-cell Leukemia/Lymphoma Virus type 1 (HTLV-1) and adult T-cell leukemia/lymphoma.
- Epstein-Barr virus (EBV) shows a moderate causal association with African Burkitt's lymphoma.
- Associations for EBV with Hodgkin's disease and non-Hodgkin's lymphoma, and Hepatitis C virus (HCV) with hepatocellular carcinoma are incomplete or inconclusive.
- The role of Human Papilloma Viruses (HPVs) in cervical carcinoma requires further investigation with current techniques.
Conclusions:
- The strength of evidence varies significantly for different virus-cancer associations.
- HBV and HTLV-1 represent clear examples of viral oncogenesis.
- Further research is needed to clarify the roles of EBV, HCV, and HPV in specific human cancers.